BridgeBio Pharma
BBIO
$27.83
Share price
0.32%
Change (1 day)
103.44%
Change (1 year)
Categories
BridgeBio Pharma (BBIO) - Total assets
Total assets on the balance sheet as of March 2024 : $0.84 B
According to BridgeBio Pharma 's latest financial reports the company's total assets are $0.84 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
BridgeBio Pharma - Total assets on balance sheet (from 2018 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.54 B | -12.3% |
| 2022-12-31 | $0.62 B | -38.48% |
| 2021-12-31 | $1.01 B | 43.95% |
| 2020-12-31 | $0.70 B | 11.38% |
| 2019-12-31 | $0.63 B | 35.86% |
| 2018-12-31 | $0.46 B | 374.22% |
| 2017-12-31 | $98.04 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $2.01 B | 136.86% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $22.68 M | -97.33% | 🇺🇸 USA |